Hepatocellular carcinoma biomarkers, an imminent need

Hepatocellular carcinoma (HCC) is the most common malignant neoplasm of the liver and one of the deadliest cancers worldwide. The identification of novel, highly specific and more sensitive biomarkers for HCC is crucial because existing ones are deficient and non-confirmatory without histological bi...

Descripción completa

Detalles Bibliográficos
Autor principal: Zamora-León, S Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603452/
https://www.ncbi.nlm.nih.gov/pubmed/34853655
http://dx.doi.org/10.4251/wjgo.v13.i11.1847
_version_ 1784601766990446592
author Zamora-León, S Pilar
author_facet Zamora-León, S Pilar
author_sort Zamora-León, S Pilar
collection PubMed
description Hepatocellular carcinoma (HCC) is the most common malignant neoplasm of the liver and one of the deadliest cancers worldwide. The identification of novel, highly specific and more sensitive biomarkers for HCC is crucial because existing ones are deficient and non-confirmatory without histological biopsy or imaging techniques.
format Online
Article
Text
id pubmed-8603452
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-86034522021-11-30 Hepatocellular carcinoma biomarkers, an imminent need Zamora-León, S Pilar World J Gastrointest Oncol Letter to the Editor Hepatocellular carcinoma (HCC) is the most common malignant neoplasm of the liver and one of the deadliest cancers worldwide. The identification of novel, highly specific and more sensitive biomarkers for HCC is crucial because existing ones are deficient and non-confirmatory without histological biopsy or imaging techniques. Baishideng Publishing Group Inc 2021-11-15 2021-11-15 /pmc/articles/PMC8603452/ /pubmed/34853655 http://dx.doi.org/10.4251/wjgo.v13.i11.1847 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Letter to the Editor
Zamora-León, S Pilar
Hepatocellular carcinoma biomarkers, an imminent need
title Hepatocellular carcinoma biomarkers, an imminent need
title_full Hepatocellular carcinoma biomarkers, an imminent need
title_fullStr Hepatocellular carcinoma biomarkers, an imminent need
title_full_unstemmed Hepatocellular carcinoma biomarkers, an imminent need
title_short Hepatocellular carcinoma biomarkers, an imminent need
title_sort hepatocellular carcinoma biomarkers, an imminent need
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603452/
https://www.ncbi.nlm.nih.gov/pubmed/34853655
http://dx.doi.org/10.4251/wjgo.v13.i11.1847
work_keys_str_mv AT zamoraleonspilar hepatocellularcarcinomabiomarkersanimminentneed

Ejemplares similares